Pharmacokinetic study of TRK-820 -Pharmacokinetic study among TRK-820 tablets and TRK-820 soft capsules.

Phase 1

• Conditions: Healthy Japanese Male

• Registration Number: JPRN-jRCT1080221878
• Lead Sponsor: Toray Industries,Inc.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-08-07
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Sex: Male
• Target Recruitment: 8

Inclusion Criteria

Subjects over 20 and under 40 years of age.
Subjects giving consent to enter the clinical trial.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of pharmacokinetics.<br>Measurement of unaltered TRK-820 concentration in plasma and calculation of pharmacokinetic parameters.

Secondary Outcome Measures

Name	Time	Method
Evaluation of safety.<br>Adverse Event(AE), Adverse Drug Reaction(ADR), Clinical Test, Vital Sign(VS), Electrocardiogram(ECG)(12-lead)